by side with those of type strains for identification (Fig. lc) . The identifications of six strains based on the PBP profiles coincided with those based on the API Staph method, whereas the PBP profiles of JA21 and JA187 were found to correspond to that of S. caprae (Fig. lc, lanes 20-22) . This finding was unexpected because the species had not previously been isolated from human sources, and both patients from whom these strains were isolated had no history of contact with goats. To confirm this identification, DNA-DNA hybridization was performed as described previously (6) Both strains of S. caprae were isolated from patients after continuous use of antibiotics (mostly ,-lactams) for more than 3 weeks. There was no evidence that these S. caprae strains were responsible for the patients' infections. JA21 was isolated transiently during chemotherapy of dermatitis, and JA187 was also isolated transiently during chemotherapy of a urinary tract infection caused by methicillin-resistant S. aureus. Thus, the S. caprae strains did not seem to be potent in their pathogenicity and were likely present as a result of superinfection during chemotherapy.
The prevalence of S. caprae in clinical coagulase-negative staphylococcus isolates seems to be considerably high. In Juntendo University Hospital, we have so far isolated 13 other strains of S. caprae in 1990. These isolates accounted for 11% of total methicillin-resistant coagulase-negative staphylococcus isolates. Characteristically, they were isolated transiently during chemotherapy and their causative role in infection was not evident. It was also noticed that most strains were isolated not at the time of admission but after at least a week of hospitalization, indicating the nosocomial nature of the colonization by the organism. Recently, Ezaki et al., using DNA-DNA hybridization, observed that more than 6% of 1,500 clinical coagulase-negative staphylococcus isolates belong to S. caprae (5) . On the basis of these findings, it seems likely -that at least some biotypes of the species S. caprae can inhabit the human body and are quite widely distributed in hospitals.
One of the two S. caprae strains, JA187, was resistant to methicillin and cephem antibiotics ( Table 1) . To determine whether this resistance was caused by the same genetic mechanism as that of methicillin-resistant S. aureus (13), we performed Southern blot analysis of HindIII-digested DNA of JA187 using a mecA-specific DNA probe from pMR111 (7), with a washing condition of 0.1 x SSC (1 x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for 60 min at 65°C. The result is presented in Fig. 2 . As positive controls, three methicillin-resistant staphylococcus strains were analyzed in parallel. With JA187 (Fig. 2, lane 2) , a band of about 4.2 kb which had the same migration rate as 'those of JA186 (S. hominis; lane 3) and JA187 (S. epidermidis; lane 1) and a slightly slower migration rate than the 4.0-kb band of MR108 (methicillin-resistant S. aureus; lane 4) was observed. From this result, we concluded that JA187, a clinical isolate of S. caprae, possessed the mecA gene. So far, we have observed the mecA gene among such coagulase-negative staphylococcus species as S. epidermidis, S. haemolyticus, S. saprophyticus, S. hominis, S. capitis, S. warneri, and S. simulans (unpublished observation). All of these strains are known as habitants of the human body. The presence of the mecA gene in one of the S. caprae strains indicated a wider distribution of the gene among coagulase-negative staphylococcus species than we had initially expected. We are undertaking a more extensive survey of clinical coagulase-negative staphylococcus isolates for the distribution of mecA gene.
